Laurie Stelzer Mirati Therapeutics, Inc. (MRTX) insider trading activity

MRTX Quotes by TradingView

Laurie Stelzer is Chief Financial Officer of Mirati Therapeutics, Inc.. Currently has a direct ownership of 102,312 shares of MRTX, which is worth approximately $0. The most recent transaction as insider was on Aug 09, 2023, when has been sold 22,297 shares (Common Stock) at a price of $37.0 per share, resulting in proceeds of $824,989. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 102K
0% 3M change
0% 12M change
Total Value Held $0

Laurie Stelzer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 09 2023
BUY
Grant, award, or other acquisition
$824,989 $37.0 p/Share
22,297 Added 17.89%
102,312 Common Stock
Jun 02 2023
SELL
Open market or private sale
$172,217 $37.06 p/Share
4,647 Reduced 5.49%
80,015 Common Stock
Jan 20 2023
BUY
Grant, award, or other acquisition
-
26,864 Added 24.09%
84,662 Common Stock
Jun 01 2022
BUY
Grant, award, or other acquisition
-
57,798 Added 50.0%
57,798 Common Stock

Also insider at

ARNA
ARENA PHARMACEUTICALS INC Healthcare
EVP & Chief Financial Officer
PMVP
PMV Pharmaceuticals, Inc. Healthcare
SURF
Surface Oncology, Inc. Healthcare
Director
AGLE
Aeglea BioTherapeutics, Inc. Healthcare
LS

Laurie Stelzer

Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on MRTX

Follow Mirati Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRTX shares.

Notify only if

Insider Trading

Get notified when an Mirati Therapeutics, Inc. insider buys or sells MRTX shares.

Notify only if

News

Receive news related to Mirati Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRTX